@PittetLab
Account based inSwitzerland
About this account
- Account based in
- Switzerland
- Connected via
- Switzerland App Store
Account-level information from X, not a live location or the device used for a specific post.
We aim to acquire missing knowledge to find better ways to fight cancer. Our areas of expertise are immunology and immunotherapy.
Joined May 2017
- Tweets555
- Following122
- Followers1.9K
- Likes393
The Pittet Lab retweeted
“In other words, DCs are the ‘best supporting actors’ of anti-tumor immunity.”
I guess that makes the T cell Marlon Brando!?!
“I'm gonna make this tumor cell an offer he can't refuse.“
Happy to share a link to our recent review of dendritic cells in cancer, written together with the great @MempelThorsten @csgarrix and @DiPilatoMauro.
Here is a link giving full access to the paper: authors.elsevier.com/a/1hlQ8…
Happy to share a link to our recent review of dendritic cells in cancer, written together with the great @MempelThorsten @csgarrix and @DiPilatoMauro.
Here is a link giving full access to the paper: authors.elsevier.com/a/1hlQ8…
The Pittet Lab retweeted
Bill and Wirapati et al. @RubenBill5 asked if common TME cellular processes control complex and variable patient outcomes. bit.ly/45n4gPq @PittetLab
The Pittet Lab retweeted
Read Cancer Discovery's #ResearchWatch:
CXCL9:SPP1 Macrophage Polarity Is Linked to Clinical Outcome in Cancer, summarizing the work of @RubenBill5, @MikaelPittet, @PittetLab et al.
bit.ly/45pjnaS
@Ludwig_Cancer @OncoUNILCHUV
📢 Research Alert! 🧬🔬 🩺 We are super excited that our latest study, led by the great @RubenBill5 & Asa Wirapati, is out: science.org/doi/full/10.1126…
We set out to shed some light on the tumor microenvironment and its impact on cancer progression.
🧵
8/ 🙌 Of course, it takes a village to conduct a study like this, so a hearty thank you, and bravo, to all the clinicians, nurses, researchers, bioinformaticians, technicians and many more, who made this study possible.
9/ 😀📚 If you're hungry for more insights into how patient variation may help us unravel the complexities of cancer, don't miss the full publication here: science.org/doi/full/10.1126…
The Pittet Lab retweeted
📣 📣 Do you leave close to Geneva and want to participate in an out-of-the box Virtual Reality-based neuroimmunology project? Contact us! We count on you 😊! @snsf_ch Sinergia, @LabMyspace @miupasteur
What a fantastic study!
We are thrilled that our recent study lead by @BayerlFelix is out in @ImmunityCP today. We addressed the question how cDC1 dysfunction is regulated in tumors and to which extent this contributes to cancer immune evasion. It is Open Access!👇
cell.com/immunity/fulltext/S…
A short 🧵:
The Pittet Lab retweeted
The findings suggest that researchers may be able to manipulate neutrophils to make cancer therapies more effective hms.harvard.edu/news/how-low…
❔What is special about an immune system that successfully attacks tumors, compared to one that doesn’t?
Our new study in @CellCellPress led by @jgungabeesoon, @Nich and @Mate_Kiss_ aimed to address this question. A joint work with the great @KleinLabHMS
authors.elsevier.com/a/1gqie…
👉 We also want to advertize a related paper by the team of @merghout and @wolchokj, published in the same issue, which reveals additional insights about the role of neutrophils in mediating effective cancer immunotherapy.
👉 doi.org/10.1016/j.cell.2023.…
Thank you also to Ann Ager for discussing both papers here: doi.org/10.1016/j.cell.2023.…